CClinicalTrials.gg
Not yet recruitingNCT06366035LoVE4MUMUpdated Apr 16, 2024

LoVE4MUM: Virtual Engagement for Preventing Postpartum Depression

An interventional study of LoVE4MUM mobile application in Postpartum Depression, Maternal Behavior and mHealth Intervention, sponsored by National Institutes of Health, Ministry of Health Malaysia. Not yet recruiting at 2 sites in Malaysia. Open to female participants aged 19 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-16.

Sponsored by National Institutes of Health, Ministry of Health Malaysia · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 4 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
19 Years to 50 Years
Sex
Female
01

Study summary

Postpartum depression is a serious concern affecting mothers and their infants, especially with limited traditional support. This pilot study evaluates the effectiveness of a novel mobile app called LoVE4MUM, developed based on Cognitive Behavioral Therapy and Psychoeducation principles, in preventing postpartum depression. The pilot trial involves 64 mothers randomly assigned to receive either standard care or standard care plus the LoVE4MUM. Primary outcome is improvement in depression, with secondary outcomes including mental health literacy and automatic negative thoughts. This research aims to provide initial evidence on the potential of mobile health tools to support maternal mental health, paving the way for future accessible and effective interventions.

Read the detailed description

Postpartum depression (PPD) is a significant mental health issue. Traditional support systems remains challenging and mHealth intervention provides an opportunity to access for support.

The primary objective of this study is to preliminarily assess the effectiveness of a developed mobile application called LoVE4MUM in prevention of postpartum depression. The study will employ a single-blinded, pilot randomized controlled trial (RCT) design involving a sample of 64 mothers. Participants will be randomly assigned in a 1:1 ratio to one of two groups: the intervention group, which will receive standard postpartum care plus LoVE4MUM mobile application, or the control group, which will receive standard postpartum care alone. The primary outcome measure will be the effectiveness of the mobile application in improving symptoms of postpartum depression among mothers. Secondary outcome measures will include changes in postpartum mental health literacy scores and negative automatic thoughts frequencies.

Through the systematic evaluation of the LoVE4MUM mobile application in conjunction with standard postpartum care, this pilot RCT aims to generate preliminary evidence regarding the efficacy and feasibility of using mHealth tools for preventing postpartum depression.

02

Conditions studied

  • Postpartum Depression
  • Maternal Behavior
  • mHealth Intervention
  • Mental Health Issue

Keywords

  • Postpartum Depression
  • mHealth intervention
  • self-guided
  • postpartum mental health literacy
03

In context

Depression, Postpartum

528 studies on the registry are indexed under Depression, Postpartum; 124 are open to participants now.

This study's planned enrollment of 64 is below the median of 105 across 425 interventional studies indexed under Depression, Postpartum.

Browse Depression, Postpartum studies →

Lead sponsor

This is the only study on the registry with National Institutes of Health, Ministry of Health Malaysia as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • mothers with EPDS score 9-\<12
  • mothers with access to smartphone and internet connectivity
  • continue routine postpartum care at the government health facilities
  • literate in english and malay

Exclusion criteria

Exclusion Criteria:

  • history of drug abuse
  • diagnosis of depressive illness or any other mental health illness
  • undergoing treatment for mental health
  • infant born with intrauterine death or died immediately after birth
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
64 participants (estimated)

Study arms

  • No intervention
    Treatment as Usual (TAU)

    Mothers receiving treatment as usual (TAU) at the postpartum health care facilities according to standard guideline from period of delivery up to 6 weeks postpartum

  • Experimental
    Treatment as Usual & LoVE4MUM phone application

    Mothers receiving treatment as usual (TAU) and LoVE4MUM phone application from period of delivery up to 6 weeks postpartum

    Device: LoVE4MUM mobile application

Interventions

  • DeviceLoVE4MUM mobile application

    LoVE4MUM is an innovative mobile application developed based on cognitive behavioral therapy and psychoeducation. The mobile application consist of 5 main modules which delivers information pertaining self-care, postpartum depression, handling negative thoughts, mood tracking and information for seeking help. The module consist of short notes, videos and worksheets for the participants to conduct.

06

What researchers measure

Primary outcomes

  1. Postpartum Depression

    Self report measure using the Edinburgh Postpartum Depression Scale (EPDS) by the subjects on their symptoms of emotional distress during pregnancy and the postnatal period. Scale has been validated in English and Malay language with a total of 10 items based on 4 point Likert scale (0-3). Expected scoring 0 - 30. Score above 12 is considered probable depression.

    Time frame: Baseline, 1 week and 6 weeks postpartum

Secondary outcomes

  1. Postpartum Mental Health Literacy

    self report measure using the Postpartum Depression Literacy Scale (PoDLiS) by the subjects on their knowledge and attitude on postpartum depression, help seeking, symptoms and available support. It has been validated in English and the Malay language. The 31 items is rated on a 5 point Likert scale (1-5). Total score is the total raw score divided by the total item. Higher score equivalents to higher postpartum mental health literacy

    Time frame: Baseline, 1 week and 6 weeks postpartum

  2. Automatic Negative Frequency

    self report measure using the Automatic Thoughts Questionnaire (ATQ) by the subjects on the frequency of experiencing the negative thought statement. It has been validated in the English and Malay language. The 17 items is rated based on a 5 point Likert scale (1-5). Total score 17- 85. Higher score equivalent to higher frequency of negative thoughts.

    Time frame: Baseline, 1 week and 6 weeks postpartum

07

Study locations

2 sites
  • Hospital Tengku Ampuan Rahimah
    Klang, Selangor 41586, Malaysia
    • Noor Fadzleeyanna Mohd Yahaya, MOG · Contact · 03-3375 7000
    • Noor Fadzleeyanna Mohd Yahaya, MOG · Principal investigator
    • Shalisah Sarip, PhD · Sub investigator
    • Norfazilah Ahmad, PhD · Sub investigator
  • Hospital Shah Alam
    Shah Alam, Selangor 40000, Malaysia
    • Siti Sabrina Kamarudin · Contact · saby721@gmail.com · 0355263000
    • Siti Sabrina Kamarudin, MBBS · Principal investigator
    • NNurul Syuhaida Abdul Razak, MOG · Sub investigator
    • Idayu Badilla Idris, PhD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — information could be available upon reaching out to the principal investigator. However date relative to the time when summary data are published or otherwise made available starting 6 months after publication.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06366035
Lead sponsor
National Institutes of Health, Ministry of Health Malaysia
Responsible party
Siti Sabrina binti Kamarudin (Principal Investigator, National Institutes of Health, Ministry of Health Malaysia) — Principal investigator
First posted
Apr 15, 2024
Start date
Apr 22, 2024 (estimated)
Primary completion
Jun 3, 2024 (estimated)
Completion
Oct 1, 2024 (estimated)
Last update
Apr 16, 2024

Study contacts

Siti Sabrina Kamarudin, MBBS
Contact
saby721@gmail.com
0355263000
Idayu Badilla Idris, PhD
Contact
idayubadilla.idris@ukm.edu.my
603 - 9145 5887
Siti Sabrina Kamarudin, MBBS
principal investigator · National Institute for Health, NIH Malaysia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion